Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-054959
Filing Date
2020-05-01
Accepted
2020-05-01 07:30:35
Documents
1
Effectiveness Date
2020-05-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A a20-18335_2defa14a.htm DEFA14A 39869
  Complete submission text file 0001104659-20-054959.txt   40998
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31918 | Film No.: 20838349
SIC: 2836 Biological Products, (No Diagnostic Substances)